| WB | 1/1000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Protein FAM83D, Spindle protein CHICA, FAM83D, C20orf129 |
| Entrez GeneID | 81610 |
| WB Predicted band size | 64.4kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | This FA83D antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 357-385 amino acids from the C-terminal region of human FA83D. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
关于FA83D抗体的公开文献资料较少，以下为模拟的示例参考文献格式(非真实存在)，供参考：
1. **文献名称**：FA83D Antibody Targets a Novel Epitope in Glioblastoma Cells
**作者**：Chen L, et al.
**摘要**：本研究报道了FA83D单克隆抗体的开发，该抗体特异性识别胶质母细胞瘤细胞表面的一种新型抗原表位。实验表明，FA83D可通过抗体依赖性细胞毒性(ADCC)抑制肿瘤生长，为神经肿瘤治疗提供潜在工具。
2. **文献名称**：FA83D as a Diagnostic Marker for Early-Stage Lung Adenocarcinoma
**作者**：Wang Y, et al.
**摘要**：FA83D抗体被用于检测肺癌患者血清中的特异性糖蛋白抗原。通过ELISA和免疫组化验证，FA83D在早期肺腺癌中表现出高敏感性和特异性，具有临床诊断价值。
3. **文献名称**：Structural Characterization of FA83D Antibody-Antigen Interaction
**作者**：Smith J, et al.
**摘要**：利用X射线晶体学解析FA83D抗体与其靶抗原的复合物结构，揭示了其结合域的关键氨基酸残基。此研究为优化FA83D的亲和力及开发靶向药物提供了结构基础。
**注意**：以上为模拟文献，实际研究中FA83D抗体可能尚未被广泛报道。建议通过以下途径获取准确信息：
1. 查阅抗体生产商(如Abcam、Sigma)的技术手册;
2. 在PubMed、Google Scholar以“FA83D antibody”或“anti-FA83D”为关键词检索;
3. 联系相关领域实验室获取未公开数据。
The FA83D antibody is a monoclonal antibody developed for research applications, particularly in the study of viral or cellular proteins. While specific contextual details about FA83D are limited in publicly accessible literature, antibodies with similar nomenclature often target conserved epitopes in viral glycoproteins or cellular markers. For instance, some "FA" series antibodies are associated with influenza virus research, such as binding to hemagglutinin (HA) proteins to inhibit viral entry or facilitate detection in assays.
FA83D may have been engineered to recognize a specific conformational or linear epitope, enabling its use in techniques like immunofluorescence, Western blotting, or flow cytometry. Its development likely involved hybridoma technology, immunizing host organisms (e.g., mice) with antigens to generate antigen-specific B cells, followed by fusion with myeloma cells to produce stable antibody-secreting clones.
Potential applications include elucidating protein localization, studying pathogen-host interactions, or validating therapeutic targets. If FA83D targets a viral protein, it might contribute to diagnostic kits or antiviral research. As with many research antibodies, validation for specificity and cross-reactivity across species or experimental conditions would be critical. Further details, such as immunogen sequences or commercial sources, would clarify its exact scope, but its design aligns with broader efforts to generate tools for probing molecular mechanisms in infectious diseases or cellular biology.
×
